Literature DB >> 18945784

Brain trauma enhances transient cytomegalovirus invasion of the brain only in mice that are immunodeficient.

Anthony N van den Pol1.   

Abstract

Cytomegalovirus (CMV) is one of the most common viral pathogens leading to neurological dysfunction in individuals with depressed immune systems. How CMV enters the brain remains an open question. The hypothesis that brain injury may enhance the entrance of CMV into the brain was tested. Insertion of a sterile needle into the brain caused a dramatic increase in mouse CMV in the brains of immunodeficient SCID mice inoculated peripherally within an hour of injury and examined 1 week later; peripheral inoculation 48 h after injury and a 1-week survival resulted in only a modest infection at the site of injury. In contrast, uninjured SCID mice, as well as injured immunocompetent control mice, showed little sign of viral infection at the same time intervals. Direct inoculation of the brain resulted in widespread dispersal and enhanced replication of mCMV in SCID brains tested 1 week later but not in parallel control brains. Differential viremia was unlikely to account for the greater viral load in the SCID brain, since increased mCMV in the blood of SCID compared to controls was not detected until a longer interval. These data suggest that brain injury enhances CMV invasion of the brain, but only when the adaptive immune system is compromised, and that the brain's ability to resist viral infection recovers rapidly after injury.

Entities:  

Mesh:

Year:  2008        PMID: 18945784      PMCID: PMC2612325          DOI: 10.1128/JVI.01728-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

Review 1.  The blood-brain barrier in neuroinflammatory diseases.

Authors:  H E de Vries; J Kuiper; A G de Boer; T J Van Berkel; D D Breimer
Journal:  Pharmacol Rev       Date:  1997-06       Impact factor: 25.468

Review 2.  Management of cytomegalovirus infection and disease after solid-organ transplantation.

Authors:  W van der Bij; R Speich
Journal:  Clin Infect Dis       Date:  2001-07-01       Impact factor: 9.079

3.  Cellular localization of latent murine cytomegalovirus.

Authors:  A J Koffron; M Hummel; B K Patterson; S Yan; D B Kaufman; J P Fryer; F P Stuart; M I Abecassis
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Experimental murine cytomegalovirus infection in severe combined immunodeficient mice.

Authors:  R P Reynolds; R J Rahija; D I Schenkman; C B Richter
Journal:  Lab Anim Sci       Date:  1993-08

5.  Congenital cytomegalovirus infection and neonatal auditory screening.

Authors:  T Hicks; K Fowler; M Richardson; A Dahle; L Adams; R Pass
Journal:  J Pediatr       Date:  1993-11       Impact factor: 4.406

6.  Cytomegalovirus infection of the brain in AIDS: a clinicopathological study.

Authors:  U Setinek; E Wondrusch; K Jellinger; A Steuer; M Drlicek; W Grisold; F Lintner
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; S Aiba-Masago; I Kosugi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Neuroradiographic abnormalities in congenital cytomegalovirus infection.

Authors:  J F Bale; P F Bray; W E Bell
Journal:  Pediatr Neurol       Date:  1985 Jan-Feb       Impact factor: 3.372

9.  Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system.

Authors:  J R Arribas; D B Clifford; C J Fichtenbaum; D L Commins; W G Powderly; G A Storch
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow.

Authors:  E J Minton; C Tysoe; J H Sinclair; J G Sissons
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more
  1 in total

1.  Polio, still lurking in the shadows.

Authors:  Anthony N van den Pol
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.